Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PASO: Sorafenib + Paclitaxel in Metastatic Breast Cancer
NCT01320111Phase 2Completed
- Sponsor
- GMIHO Gesellschaft für Medizinische Innovation - Hämatologie und Onkologie
- Start
- Jul 2010
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib in breast cancer, sponsored by GMIHO Gesellschaft für Medizinische Innovation - Hämatologie und Onkologie. Started Jul 2010; status: completed.
02
Drugs
sorafenib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01320111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01320111.